DLRHX Mutual Fund

DLRHX Mutual Fund

NAV$25.92
See how much of DLRHX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$2M
Expense Ratio
1.46%
Dividend Yield (Current)
2.37%
Holdings
106
Inception Date
Jan 28, 2010
Fund Family
Nomura Asset Management Co Ltd
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
SEC 30-Day Yield
PRO

Performance

YTD+5.48%
1 Year+18.86%
3 Year+14.80%
5 Year+8.18%
10 Year+10.95%

Asset Allocation

Stocks: 98.46%
Cash: 1.15%
Other: 0.40%
See how much of DLRHX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
REGNRegeneron Pharmaceuticals, Inc.4.82%
UCB:BRUcb Sa4.49%
ABBVAbbvie Inc.4.22%
PFEPfizer Inc4.06%
LLYEli Lilly & Co.4.02%
Top 10 Concentration: 39.36%Report Date: Jul 31, 2026
Download all 106 holdings for DLRHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.37%
Latest Distribution
$1.48
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

DLRHX Mutual Fund Overview

DLRHX Mutual Fund (Nomura Healthcare Fund Class R) is managed by Nomura Asset Management Co Ltd with $2.3M in net assets. DLRHX expense ratio is 1.46%, holding 106 positions across sectors including Health Care, Financials, Consumer Staples. Inception date: 2010-01-28.

DLRHX performance shows a YTD return of 5.48%. The 1-year return is 18.86% and the 5-year return is 8.18%. DLRHX dividend yield stands at 2.37%.

DLRHX top holdings include Regeneron Pharmaceuticals, Inc. (4.8%), Ucb Sa (4.5%), Abbvie Inc. (4.2%), Pfizer Inc (4.1%), Eli Lilly & Co. (4.0%). Go to all DLRHX holdings, DLRHX sectors, or DLRHX dividends.

DLRHX can be compared against other funds. Use DLRHX overlap to find shared positions, or DLRHX vs another fund for a side-by-side view. DLRHX alternatives are available via the screener, along with tax-loss harvesting opportunities.